from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2484c/-

LFCtreatmentdescriptionclass of inhibitor

0.713

Amikacinug/mL Amikacintranslation

-0.959

Cap5-10ug/mL Capreomycintranslation

-1.057

Rox10-50 ug/mL Roxithromycintranslation

-0.108

SM2-5 ug/mL Streptomycintranslation

-0.567

Tet5-10 ug/mL Tetracyclinetranslation

0.872

Rif0.2-5ug/mL Rifampicintranscription

-0.621

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.031

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.740

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.078

CPZ10-50 ug/mL Chlorpromazinerespiration

1.198

Clofazimine10-13 ug/mL Clofaziminerespiration

0.568

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.933

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.473

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.255

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.812

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.425

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.658

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.128

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.789

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.077

KCN5-20 ug/mL Potassium cyaniderespiration

0.666

NaN30.2-2 mM Sodium aziderespiration

-0.100

Nigericin50 uM Nigericinrespiration

0.672

TRC10-150 ug/mL Triclosanrespiration

0.391

TRZ10-25 ug/mL Thioridazinerespiration

-2.483

Valinomycin0.5-10 uM Valinomycinrespiration

-0.154

ZnSO42 mM ZnSO4respiration

1.149

menadione6-10 ug/mL Menadionerespiration

-0.444

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.656

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.060

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.650

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.334

NRP_1Non-replicating persistence stage 1dosRassociated

-0.106

Amp0.2mg/mL AmpicillincellWall

-0.801

Cephalexin20-100 ug/mL CephalexincellWall

-1.206

Cerulenin0.32-5 ug/mL CerulenincellWall

0.120

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.177

EMB10-20 ug/mL EthambutolcellWall

-0.722

Eta12-40 ug/mL EthionamidecellWall

-0.667

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.631

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.639

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.352

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.368

BZA0.12 mg/mL BenzamidearomaticAmides

0.533

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.054

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.151

H2O24 mM hydrogen peroxideDNAdamaging

0.193

Levo10 ug/mL LevofloxacinDNAdamaging

0.010

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.207

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.582

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.336

UVUV-irradiationDNAdamaging

0.284

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.465

Antimycin12.5-50 ug/mL Antimycin A?

-0.745

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.030

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.154

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.905

PA8240.2-2 ug/mL PA-824?

-0.251

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.276

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.638

Verapamil50 uM Verapamil?

-0.393

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.757

methoxatin10-20 ug/mL Methoxatin?